• Zinzino reported July 2026 group revenue of SEK 315.9 million, up 20% year on year.
• Zinzino sales markets generated SEK 313.4 million, up 20%; Faun Pharma external sales were SEK 2.5 million, up 14%.
• January–July 2026 group revenue rose 22% to SEK 2.17 billion.
• Central Europe revenue climbed 28% to SEK 98.1 million; North America increased 36% to SEK 64.4 million; Asia-Pacific rose 71% to SEK 34.3 million.
• Nordics revenue fell 6% to SEK 24.5 million; East Europe declined 13% to SEK 27.4 million; Baltics dropped 13% to SEK 8.7 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zinzino AB published the original content used to generate this news brief via Cision (Ref. ID: 202608050300BITN____UKPR__EN_20260804-BIT-4320-0) on August 05, 2026, and is solely responsible for the information contained therein.